Search Results - "Pollom, Erqi L."

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma by Wahl, Daniel R, Stenmark, Matthew H, Tao, Yebin, Pollom, Erqi L, Caoili, Elaine M, Lawrence, Theodore S, Schipper, Matthew J, Feng, Mary

“…Data guiding selection of nonsurgical treatment of hepatocellular carcinoma (HCC) are lacking. We therefore compared outcomes between stereotactic body…”
Get full text

Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer by Wu, Jia, Gensheimer, Michael F, Zhang, Nasha, Guo, Meiying, Liang, Rachel, Zhang, Carrie, Fischbein, Nancy, Pollom, Erqi L, Beadle, Beth, Le, Quynh-Thu, Li, Ruijiang

“…The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has been rapidly increasing. Disease stage and smoking history are often used in current…”
Get full text

Survival after neoadjuvant approaches to gastroesophageal junction cancer by Xiang, Michael, Chang, Daniel T., Heestand, Gregory M., Pollom, Erqi L.

“…Background Gastroesophageal junction (GEJ) cancers can be treated with equipoise using neoadjuvant chemoradiation (NACRT) or chemotherapy alone (NAC), but the…”
Get full text

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer by Durkee, Ben Y, Qian, Yushen, Pollom, Erqi L, King, Martin T, Dudley, Sara A, Shaffer, Jenny L, Chang, Daniel T, Gibbs, Iris C, Goldhaber-Fiebert, Jeremy D, Horst, Kathleen C

“…The Clinical Evaluation of Pertuzumab and Trastuzumab (CLEOPATRA) study showed a 15.7-month survival benefit with the addition of pertuzumab to docetaxel and…”
Get full text

Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy by Pollom, Erqi L., MD, Chin, Alexander L., MD, MBA, Diehn, Maximilian, MD, PhD, Loo, Billy W., Jr, MD, PhD, Chang, Daniel T., MD

“…Although stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy has become an established standard of care for the treatment of a variety…”
Get full text

Single- versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity by Pollom, Erqi L., MD, Alagappan, Muthuraman, BS, von Eyben, Rie, MS, Kunz, Pamela L., MD, Fisher, George A., MD, Ford, James A., MD, Poultsides, George A., MD, Visser, Brendan C., MD, Norton, Jeffrey A., MD, Kamaya, Aya, MD, Cox, Veronica L., MD, Columbo, Laurie A., RN, Koong, Albert C., MD, PhD, Chang, Daniel T., MD

“…Purpose We report updated outcomes of single- versus multifraction stereotactic body radiation therapy (SBRT) for unresectable pancreatic adenocarcinoma…”
Get full text

Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy by Pollom, Erqi L., MD, Deng, Lei, MBBS, Pai, Reetesh K., MD, Brown, J. Martin, PhD, Giaccia, Amato, PhD, Loo, Billy W., MD, PhD, Shultz, David B., MD, PhD, Le, Quynh Thu, MD, Koong, Albert C., MD, PhD, Chang, Daniel T., MD

“…Combining the latest targeted biologic agents with the most advanced radiation technologies has been an exciting development in the treatment of cancer…”
Get full text

Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery by Wang, Jen-Yeu, Qu, Vera, Hui, Caressa, Sandhu, Navjot, Mendoza, Maria G, Panjwani, Neil, Chang, Yu-Cheng, Liang, Chih-Hung, Lu, Jen-Tang, Wang, Lei, Kovalchuk, Nataliya, Gensheimer, Michael F, Soltys, Scott G, Pollom, Erqi L

“…Artificial intelligence-based tools can be leveraged to improve detection and segmentation of brain metastases for stereotactic radiosurgery (SRS). VBrain by…”
Get full text

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma by Pollom, Erqi L, Bui, Timothy T, Chang, Anne Lynn S, Colevas, A Dimitrios, Hara, Wendy Y

“…Vismodegib is a targeted agent recently approved for treating patients who develop recurrent or locally advanced basal cell carcinoma (BCC), and will…”
Get more information

Clinical impact of the VOLO optimizer on treatment plan quality and clinical treatment efficiency for CyberKnife by Schüler, Emil, Lo, Anthony, Chuang, Cynthia F., Soltys, Scott G., Pollom, Erqi L., Wang, Lei

“…With the recent CyberKnife treatment planning system (TPS) upgrade from Precision 1.0 to Precision 2.0, the new VOLO optimizer was released for plan…”
Get full text

Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study by Pollom, Erqi L, Lee, Kyueun, Durkee, Ben Y, Grade, Madeline, Mokhtari, Daniel A, Wahl, Daniel R, Feng, Mary, Kothary, Nishita, Koong, Albert C, Owens, Douglas K, Goldhaber-Fiebert, Jeremy, Chang, Daniel T

“…Purpose To assess the cost-effectiveness of stereotactic body radiation therapy (SBRT) versus radiofrequency ablation (RFA) for patients with inoperable…”
Get full text

Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients by Pollom, Erqi L., MD, MS, Chin, Alexander L., MD, MBA, Lee, Nancy Y., MD, Tsai, C. Jillian, MD, PhD

“…Purpose To characterize the patterns of care and potential barriers to access to care for elderly patients with oral cavity cancer in the adjuvant setting…”
Get full text

The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma by Pollom, Erqi L., MD, Wang, Guanying, MD, Harris, Jeremy P., MD, MPhil, Koong, Albert C., MD, PhD, Bendavid, Eran, MD, MS, Bhattacharya, Jay, MD, PhD, Chang, Daniel T., MD

“…Purpose We examined the impact of intensity modulated radiation therapy (IMRT) on hospitalization rates in the Surveillance, Epidemiology, and End Results…”
Get full text

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging by Alhusaini, Saud, Lanman, Tyler A, Ko, Ryan B, Therkelsen, Kate E, Eyben, Rie Von, Diehn, Maximilian, Soltys, Scott G, Pollom, Erqi L, Chin, Alexander, Vitzthum, Lucas, Wakelee, Heather A, Padda, Sukhmani K, Ramchandran, Kavitha, Loo, Jr, Billy W, Neal, Joel W, Nagpal, Seema

“…The 2-year incidence of brain metastases (BrMs) in stage III non-small lung cell cancer (NSCLC) has been estimated to be around 30%. However, recent clinical…”
Get full text

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study by Guzauskas, Gregory F, Pollom, Erqi L, Stieber, Volker W, Wang, Bruce C M, Garrison, Jr, Louis P

“…The EF-14 trial demonstrated that adding tumor treating fields (TTFields) to maintenance temozolomide (TMZ) significantly extends progression-free survival…”
Get more information

Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma by Jin, Michael C., Wu, Adela, Xiang, Michael, Azad, Tej D., Soltys, Scott G., Li, Gordon, Pollom, Erqi L.

“…There is a lack of literature guiding treatment of giant cell glioblastoma (gcGBM), a rare subtype of glioblastoma (GBM). We used a national hospital-based…”
Get full text

Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy by Xiang, Michael, Chang, Daniel T., Pollom, Erqi L.

“…Background The comparative risks of a second cancer diagnosis are uncertain after primary cancer treatment with 3‐dimensional conformal radiotherapy (3DCRT),…”
Get full text

Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma by Jin, Michael C, Liu, Elisa K, Shi, Siyu, Gibbs, Iris C, Thomas, Reena, Recht, Lawrence, Soltys, Scott G, Pollom, Erqi L, Chang, Steven D, Hayden Gephart, Melanie, Nagpal, Seema, Li, Gordon

“…Gliosarcomas are clinically aggressive tumors, histologically distinct from glioblastoma. Data regarding the impact of extent of resection and post-operative…”
Get full text

Impact of mental illness on end‐of‐life emergency department use in elderly patients with gastrointestinal malignancies by Kashyap, Mehr, Harris, Jeremy P., Chang, Daniel T., Pollom, Erqi L.

“…Background Elderly patients with gastrointestinal cancer and mental illness have significant comorbidities that can impact the quality of their care. We…”
Get full text

Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas by Shi, Siyu, Jin, Michael C, Koenig, Julie, Gibbs, Iris C, Soltys, Scott G, Chang, Steven D, Li, Gordon, Hayden Gephart, Melanie, Hiniker, Susan M, Pollom, Erqi L

“…We report efficacy and toxicity outcomes with stereotactic radiosurgery (SRS) for intracranial and spinal ependymoma. We analyzed adult and pediatric patients…”
Get more information